Star Imaging and Path Lab Ltd (544482) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 544482 | NSE: | Hospital & Healthcare Services | Small Cap

Star Imaging & Path Share Price

46.29 -3.87 -7.72%
as on 30-Mar'26 16:59

DeciZen - make an informed investing decision on Star Imaging & Path

Based on:

M-Cap below 100cr DeciZen not available

Star Imaging and Path Lab stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
5.07
Market Cap:
80.6 Cr.
52-wk low:
46
52-wk high:
152

Is Star Imaging and Path Lab Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Star Imaging & Path: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Star Imaging and Path Lab Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 23.7%6.1%34.4%33.7%-
Value Creation
Index
0.7-0.61.51.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 68.958.478.583.283
Sales YoY Gr.--15.3%34.5%6%-
Adj EPS 4.70.48.611.89.1
YoY Gr.--91%1952.4%36.8%-
BVPS (₹) 13.61423.234.966.3
Adj Net
Profit
6.30.611.615.916
Cash Flow from Ops. 14.46.518.3-6-
Debt/CF from Ops. 2.14.11.7-5.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA6.5%6%
Adj EPS NANA36.3%36.8%
BVPSNANA36.9%50.5%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
34.33.146.440.618.1
Op. Profit
Mgn %
21.310.328.734.3NAN
Net Profit
Mgn %
9.1114.819.119.1
Debt to
Equity
1.61.410.7-
Working Cap
Days
02321952540
Cash Conv.
Cycle
045391070

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Star Imaging and Path Lab Ltd.

Standalone Consolidated
TTM EPS (₹) 9.1 9.1
TTM Sales (₹ Cr.) 83.2 83.5
BVPS (₹.) 66.3 66.4
Reserves (₹ Cr.) 98 98
P/BV 0.70 0.70
PE 5.07 5.06
From the Market
52 Week Low / High (₹) 46.00 / 152.00
All Time Low / High (₹) 48.11 / 152.00
Market Cap (₹ Cr.) 80.6
Equity (₹ Cr.) 17.4
Face Value (₹) 10
Industry PE 79.6

Management X-Ray of Star Imaging & Path:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Star Imaging & Path - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Star Imaging & Path

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales68.9458.3778.5083.24
Operating Expenses 54.2752.3455.9854.68
Manufacturing Costs25.5425.6230.9627.77
Material Costs11.077.948.426.82
Employee Cost 8.908.317.227.49
Other Costs 8.7610.489.3912.60
Operating Profit 14.676.0322.5228.55
Operating Profit Margin (%) 21.3%10.3%28.7%34.3%
Other Income 0.180.151.190.29
Interest 1.941.962.462.55
Depreciation 3.513.345.244.96
Exceptional Items 0000
Profit Before Tax 9.400.871621.33
Tax 3.090.303.675.42
Profit After Tax 6.300.5712.3415.91
PAT Margin (%) 9.1%1.0%15.7%19.1%
Adjusted EPS (₹)4.70.49.111.8
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 18.3618.9331.2747.06
Share Capital 1.501.501.5013.50
Reserves 16.8617.4329.7733.56
Minority Interest0000
Debt29.5226.5627.2427.90
Long Term Debt16.5814.4015.7114.87
Short Term Debt12.9412.1611.5313.03
Trade Payables3.9511.9111.389.09
Others Liabilities 6.463.6211.4313.84
Total Liabilities 58.2861.0381.3197.90

Fixed Assets

Gross Block49.1250.8264.3468.46
Accumulated Depreciation34.0537.4042.6347.53
Net Fixed Assets 15.0613.4221.7120.92
CWIP 05.5900
Investments 0.010.010.010.01
Inventories0.080.630.530.24
Trade Receivables16.1617.5832.5850.69
Cash Equivalents 8.972.1815.445.14
Others Assets 1821.6211.0420.89
Total Assets 58.2861.0381.3197.90

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 14.396.4718.25-5.96
PBT 9.400.871621.33
Adjustment 5.305.016.367.23
Changes in Working Capital 2.221.06-0.33-29.14
Tax Paid -2.53-0.47-3.79-5.39
Cash Flow From Investing Activity -4.14-8.57-6.87-3.97
Capex -4.22-8.64-6.94-4.17
Net Investments 0000
Others 0.080.080.080.20
Cash Flow From Financing Activity -6.99-4.701.89-0.37
Net Proceeds from Shares 0000
Net Proceeds from Borrowing -5.11-2.961.31-0.84
Interest Paid -1.88-1.74-2.19-2.47
Dividend Paid 0000
Others 002.772.93
Net Cash Flow 3.26-6.8013.27-10.30

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)34.333.0749.1640.63
ROCE (%)23.686.0734.3933.71
Asset Turnover Ratio1.180.981.10.93
PAT to CFO Conversion(x)2.2811.351.48-0.37
Working Capital Days
Receivable Days86105117183
Inventory Days0232
Payable Days130365505548

Star Imaging and Path Lab Ltd Stock News

Star Imaging and Path Lab Ltd FAQs

The current trading price of Star Imaging & Path on 30-Mar-2026 16:59 is ₹46.29.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 29-Mar-2026 the market cap of Star Imaging & Path stood at ₹80.64.
The latest P/E ratio of Star Imaging & Path as of 29-Mar-2026 is 5.07.
The latest P/B ratio of Star Imaging & Path as of 29-Mar-2026 is 0.70.
The 52-week high of Star Imaging & Path is ₹152.0 and the 52-week low is ₹46.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Star Imaging & Path is ₹83.24 ( Cr.) .

About Star Imaging and Path Lab Ltd

Star Imaging and Path Lab Limited was originally incorporated as a private limited company under the Companies Act, 1956 in the name and style of ‘Star Imaging & Path Lab Private Limited’ dated May 31, 2004, issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana. Subsequently, the company was converted into a Public Limited Company vide Special Resolution passed by the Shareholders at the Extra-Ordinary General Meeting, held on April 12, 2024, and consequently the name of the company was changed from ‘Star Imaging & Path Lab Private Limited’ to ‘Star Imaging and Path Lab Limited’ vide a fresh certificate of incorporation dated September 17, 2024 issued by Assistant Registrar of Companies/ Deputy Registrar of Companies/ Registrar of Companies of Central Processing Centre.

The company operates a diagnostic testing network, NABL accredited, delivering pathology, radiology, Cardiology, and Neurology services in Delhi (B2C, B2B & B2G model), Uttar Pradesh (B2G model), and Nasik (B2G Model) regions of India. It offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for the prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. 

Its diagnostic imaging and radiology services encompass X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry, and mammography. In the pathology segment, its services include biochemistry, hematology, clinical pathology, histopathology, cytopathology, microbiology, serology, and immunology. It also operates a tele-radiology hub, which is equipped with a full suite of diagnostic imaging equipment and supported by a skilled team of radiologists. This centralized facility provides significant operational efficiencies and scalability, ensuring quality diagnostic services are delivered consistently across the network.

Business area of the company

The company is primarily engaged in operating pathology and diagnostic centers. It offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for the prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. 

Services of the company

  • Radiology services
  • Pathology services
  • Diagnostic services

Awards and accreditation

  • 2015: Best Imaging Service Provider of the Year from Six Sigma Healthcare Excellence Awards.
  • 2015: IMA Natcon - 2015 Partners from Delhi Medical Association.
  • 2016: Best Diagnostic & Imaging Centre from the Abs Achievement in Business & Services Awards.
  • 2016: Certificate of Recognition for The Project Star Lifestyle Card from Health the Enterprise of Healthcare.
  • 2016: Health Technology Brand of The Year from Indian Health & Wellness Awards 2016.
  • 2017: Best Diagnostic Centre (Radiology & Laboratory Medicine) from The Health Care Achievers.
  • 2017: Excellent Contribution in Branch Activities from IMA (Indian Medical Association) Janakpuri.
  • 2019: Leading, Diagnostic & Imaging Centre from IMA Mediko Healthcare Excellence Awards.

History and milestones

  • 2004: Incorporation of the company as a private company with the name ‘Star Imaging & Path Lab Private Limited’.
  • 2011: Acquired Sole Proprietorship Firms (M/s Janta X-Ray Clinic, M/s Star Imaging & Path Lab, and M/s Star Health Care).
  • 2017: The company formed a Subsidiary ‘Staredu Education and Training Institute Private Limited’ to expand its business activities.
  • 2017: Received First Work Order under PPP (Public Private Partnership) model at Uttar Pradesh (Bijnor).
  • 2022: The company received ISO 15189:2012 from NABL for Hub.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×